XERION HEALTHCARE LIMITED
Company number 09490964 · Monitor this company
The annual accounts for this company are overdue.
The confirmation statement for this company is overdue.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£3,761,795
Balance sheet as at 2023-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2015-03-16
- Registered office
- C/O James Cowper Kreston The White Building, 1-4 Cumberland Place, Southampton, SO15 2NP
- Postcode
- SO15 2NP
- Capital
- 25 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2023-03-31
- Next due by
- 2024-12-31 Overdue
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2023-08-08
- Next due by
- 2024-08-22 Overdue
Nature of business (SIC)
- 72190 Other research and experimental development on natural sciences and engineering
Officers 3 current · 2 resigned
Group structure
Controlled by OXFORD SCIENCE ENTERPRISES PLC — since 2017-12-18
Controlled by NEW WAVE VENTURES LLP — since 2016-10-17
From persons-with-significant-control filings on the public register.
Contact details
- Website
- xerionhealthcare.co.uk
Xerion’s technology increases the ability of radiotherapy to kill cancer cells without harming healthy tissue.
The class of 2015
31%
of the 569 companies in this sector incorporated in 2015 are still active today; 66% have since been dissolved.
A fact about the year, not a forecast for this company.